Solid Biosciences Inc. (SLDB) › Shareholders' EquitySolid Biosciences Inc. (SLDB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $125.18M2019: $80.05M2020: $132.09M2021: $208.21M2022: $211.67M2023: $126.48M2024: $137.25M2025: $180.01M$180.01M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$180.01M+31.2%2024$137.25M+8.5%2023$126.48M-40.2%2022$211.67M+1.7%2021$208.21M+57.6%2020$132.09M+65.0%2019$80.05M-36.1%2018$125.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share